Test Bank for Understanding Pharmacology: Essentials for Medication Safety 3rd Edition Workman & LaCharity | All Chapters | Complete Guide A+

Test bank
|

, TestBankForUnderstandingPharmacology,Essentialsfor
| | | | | |



Medication Safety, 3rd Edition,Workman & LaCharity
| | | | | |




Chapter01: Drug Regulation, Actions, and Responses
| | | | | |




MULTIPLE |CHOICE

BASIC|CONCEPTS
|




1. Which |health |care |professional |has |the |major |responsibility|for |dispensing |prescribed
|drugs |under |the |direction |of |a |pharmacist?

a. Physician
b Nurse |practitioner
.
c. Licensed |nurse
d Pharmacy|technician
.


ANS: | D
The |physician |and |nurse |practitioner |have |the |major |responsibility |for |prescribing |drugs, |not
|dispensing |them. |The |licensed |nurse |has |the |primary |responsibility |for |administering |drugs,

|although |under |some |circumstances |a |licensed |nurse |may|dispense |prescribed |drugs |but |this |is |not

|his |or |her |major |responsibility |in |drug |therapy. |The |pharmacy |technician |has |the |major

|responsibility |of |dispensing |prescribed |drugs |under |the |direction |of |a |licensed |pharmacist.




DIF: Cognitive |Level: |Remembering REF: p. |3

2. Which |term |describes |the |effect |of |a |drug |that |improves |body |function?
a. Side |effect
b Intended |action
.
c. Adverse |reaction
d Idiosyncratic |response
.


ANS: | B
The |purpose |of |drug |therapy |is |to |take |a |drug |to |prevent, |reduce, |or |correct |a |health |problem. |This
|response |is |any |drug’s |intended |action |also |known |as |a |therapeutic |response.




DIF: Cognitive |Level: |Remembering REF: p. |3

3. Which |type |of |drug |name |is |“owned” |by|the |company|that |manufactures |it?
a. Generic |name
b Chemical |name

, .
c. Category|name
d Trade |name
.


ANS: | D
The |chemical |name |is |a |drug’s |exact |chemical |composition. |The |generic |name |is |the |name
|assigned |to |the |drug |by |the |U.S. |Adopted |Names |Council |and |is |not |owned |by |anyone. |The

|category |name |refers |to |the |type |of |drug |(what |it |does |or |what |it |is |used |for) |and |is |not |an |actual |drug

|name. |The |trade |name |(brand |name) |is |the |name |provided |and |owned |by |a |specific |drug’s

|manufacturer.




DIF: Cognitive |Level: |Remembering REF: p. |4

4. Which |drug |or |drug |class |is |a |“high |alert” |drug?
a. Penicillin
b Insulin
.
c. NSAIDs
d Calcium
.


ANS: | B
A |high |alert |drug |is |one |in |which |harm |is |likely |to |result |if |given |at |the |wrong |dose, |to |the |wrong
|patient, |or |not |given |to |the |correct |patient. |Drugs |classified |as |high |alert |drugs |include |potassium,

|narcotics |(opioids), |insulin, |cancer |chemotherapy |drugs, |and |heparin |(or |any |drug |that |strongly

|affects |blood |clotting). |Penicillin, |NSAIDs, |and |calcium |are |not |considered |high |alert |drugs.




DIF: Cognitive |Level: |Remembering REF: p. |4

5. What |is |the |term |for |a |drug |that |has |the |same |action |as |a |naturally |occurring |body
|hormone |or |enzyme?

a. Agonist
b Blocking |agent
.
c. Chemical
d Duplicator
.


ANS: | A
A |drug |agonist |is |an |extrinsic |drug |that |activates |the |receptor |sites |of |a |cell |and |mimics |the |actions
|of |naturally |occurring |body |substances |(intrinsic |drugs). |A |blocking |agent |is |a |drug

, antagonist. |A |chemical |would |not |necessarily|be |a |drug |at |all. |A |duplicator |is |not |a |pharmacologic |term.

DIF: Cognitive |Level: |Remembering REF: pp. |6-7

6. Which |term |describes |how |the |body|affects |drug |activity?
a. Drug |potency
b Pharmacodynamics
.
c. Therapeutic |effect
d Pharmacokinetics
.


ANS: | D
The |term |pharmacokinetics |refers |to |drug |metabolism |and |how |the |body |changes |a |drug.
|Pharmacodynamics |refers |to |how |a |drug |works |to |change |body |function. |Drug |potency |refers |to

|how |strongly |or |to |what |degree |a |drug |exerts |its |effects. |The |therapeutic |effect |is |closer |to

|pharmacodynamics, |meaning |how |a |drug |works |to |change |body |function.




DIF: Cognitive |Level: |Remembering REF: p. |10

7. In |the |United |States, |which |group |is |responsible |for |enforcing |established |standards |for
|drug |manufacturing?

a. U.S. |Pharmacopeia
b National |Institutes |of |Health
.
c. Food |and |Drug |Administration
d Association |of |Pharmaceutical |Manufacturers
.


ANS: | C
The |standards |for |drug |manufacture |are |established |by |the |U.S. |Pharmacopeia. |These |standards
|are |enforced |by |the |Food |and |Drug |Administration. |Neither |the |National |Institutes |of |Health |nor

|the |Association |of |Pharmaceutical |Manufacturers |has |any |authority |to |enforce |drug |standards.




DIF: | | Cognitive |Level: |Remembering | | | REF: | | p. |5

8. Which |factor |is |a |major |disadvantage |of |the |transdermal |drug |delivery |route?
a. Only|a |prescriber |can |administer |drugs |by|the |transdermal |route.
b Transdermal |drugs |must |be |sterile |rather |than |clean.
.
c. First |pass |drug |loss |by|this |route |is |the |most |extensive.
d Drug |absorption |is |dependent |on |adequate |circulation.